Eli Lilly reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but saw lower ... to tamp down a person's appetite and regulate their blood ...
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment ... and regulate their blood sugar.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback